[ Price : $8.95]
Federal Register Notice: FDA releases a compliance guidance for small businesses on labeling and effectiveness testing for OTC sun...[ Price : $8.95]
Groups form consortium to develop endpoints for multiple sclerosis trials.[ Price : $8.95]
FDA asks the Neurologic Devices Panel to comment on the safety and effectiveness of the CoAxia NeuroFlo catheter based on premarke...[ Price : $8.95]
In an unprecedented move, three CDRH officials address review/approval slowness on a diabetes patient blog.[ Price : $8.95]
FDA says labels for two heparin products will change to list the strength of the entire container of the medication and how much o...[ Price : $8.95]
Trimel Pharmaceuticals says it is preparing an NDA for CompleoTRT (testosterone) for use as a replacement therapy.[ Price : $8.95]
FDA clears a Lipocine Phase 3 study of its oral testosterone replacement therapy.[ Price : $8.95]
Federal Register Notice: FDA releases a guidance, Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products.